Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, December 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 71 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 2,943 followers.

Infliximab vs. adalimumab in #Crohn's disease https://t.co/Bksoi2EDrf #IBD #Infliximab vs. #adalimumab READ THE WHOLE REPORT FREE

#Infliximab vs. #adalimumab in #Crohn's disease https://t.co/Bksoi2EDrf #IBD READ THE WHOLE REPORT FREE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.